Skip to Main Content

Paper Details

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science
1784
2020
COVID-19, COVID-19 pneumonia, IFN-, IFN-), IgG, Patients, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, SARS-CoV-2), coronavirus disease 2019 (COVID-19) pneumonia, immunoglobulin G, inborn errors of type I IFN immunity, interferon-, men, patients, severe acute respiratory syndrome coronavirus 2, type I IFN, type I IFNs, women
Author NameAffiliation
Hans-Heinrich HoffmannThe Rockefeller University
Alexandre Bolze
Giorgio CasariIRCCS San Raffaele Hospital and Vita-Salute San Raffaele University
Kaya BilguvarYale University School of Medicine
Richard P LiftonYale University School of Medicine
Richard P LiftonThe Rockefeller University
Richard P LiftonYale Center for Genome Analysis, Yale University School of Medicine
Richard P LiftonYale University School of Medicine
Richard P LiftonYale Center for Genome Analysis, Yale University School of Medicine
Richard P LiftonThe Rockefeller University
Charles M RiceThe Rockefeller University
  • 1 - 11

Datasets

Release 1.2